Tamil Nadu COVID-19 Pass apply @epasskki.in website

Tamil Nadu COVID-19 Pass register at epasskki.in- The government of Tamil Nadu officially launched the e-pass website for travel during the curfew.  Across the Tamil Nadu govt imposed 21 days lockdown in view of the situation on account of the threat of Novel Coronavirus (COVID-19). Due to lockdown, Tamil Nadu State Govt developed a web-based online portal to provide the e-pass for vehicular who are provided essential services.

The vehicular from Tamil Nadu state (All districts) looking to submit an application for e-pass to travel during the curfew. Check how to register for epasskki.in e-pass, how to check status & how to print e-pass from the official website.

How To Apply Tamil Nadu COVID-19 Pass at epasskki.in

1st Step: Visit e-pass district collectorate website epasskki.in

2nd Step: Enter your mobile number

3rd Step: Enter mobile verification code is which sent to your mobile number

4th Step: Verify OTP

5th Step: After that select category i.e industry/ manufacturer/ delivery, wholesaler, groceries, retailer, doctor, nurse/ paramedic, chemist, pharmacy, other

6th Step: Select purpose (For transport- vehicle moving/ for person-going for work)

7th Step: Select purpose type

8th Step: Enter name, document type (Aadhaar/ Driving Licence/ Ration Card/ Voter ID), Document Number

9th Step: Select from the district to the district

9th Step: Enter from area to area

10th Step: Select vehicle type (Moped/ Scooter/ Sedan Card etc) & Vehicle number

11th Step: Enter Office name, Office phone number

12th Step: Enter your address, Upload the document (Below 2 MB)

13th Step: Enter additional members

14th Step: Proceed to Submit epasskki.in application form

TN COVID-19 Epass Instructions 

Epass is being issued for those who are engaged in proving essential services like manufacturing, transport, storage and shops but do not have government or private id

This form is being launched only for such people

Others kindly do not submit this form

For more TN Covid-19 Updates follow zeal study